INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Most active filers · 30d

  1. 01Kurtz George0B / 204S204 trades$51.20M
  2. 02SPSaba Capital Management, L.P.70B / 21S · 11 late91 trades$26.34M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  6. 06SJSheena Jonathan0B / 43S43 trades$3.14M
  7. 07SLSpeiser Michael L0B / 35S35 trades$14.00M
  8. 08RARothblatt Martine A0B / 33S33 trades$5.50M
  9. 09RJRubinstein Julie0B / 33S33 trades$5.33M
  10. 10CECrimmins David Edward0B / 31S31 trades$723K

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  7. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  8. SELLULCCFrontier Group Holdings, Inc.Nov 5 – Nov 117 insiders$1.31M

Form 4 transactions

68,650 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
5
LA
Leggett Michael AdamSr VP & Chief Supply Chain Off
LZBLA-Z-BOY INC
Tax withholding
F$27K
659 sh
Jun 26, 2026Jun 29, 2026
Page 605 of 1717
← PrevNext →
traded Jun 26, 2026
+3d
SEC Form 4

Evidence

5
JA
Jimenez Freddy A.SVP & GENERAL COUNSEL
CLDXCelldex Therapeutics, Inc.
Grant or award
A—
93.0K sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

5
SI
Snook Gregory IDirector
FRAFFRANKLIN FINANCIAL SERVICES CORP /PA/
Grant or award
A$6,447
102 sh
Jun 29, 2026Jun 29, 2026
traded Jun 29, 2026
+0dSEC Form 4

Evidence

5
GR
Giroux RichardCFO & COO
MGTXMeiraGTx Holdings plc
Grant or award
A—
980.0K sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

5
NT
Navratil TomasCHIEF DEVELOPMENT OFFICER
GKOSGLAUKOS Corp
Tax withholding
F$69K
483 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

5
GK
Goodrich KatherineDirector
TARSTarsus Pharmaceuticals, Inc.
Grant or award
A—
3,837 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

5
ML
McCurry Jennifer LynnChief Accounting Officer
LZBLA-Z-BOY INC
Tax withholding
F$5,569
136 sh
Jun 28, 2026Jun 29, 2026
traded Jun 28, 2026
+1dSEC Form 4

Evidence

4
DS
Dhanasekaran SatishDirector, President and CEO
KEYSKeysight Technologies, Inc.
Open-market sale · 10b5-1 plan
SELL$183K
507 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

4
KR
Kumaraswami RaviPres. Worldwide Field Ops.
RSKDRISKIFIED LTD.
Open-market sale · 10b5-1 plan
SELL$167K
33.4K sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

4
CJ
Camblong JurgiDirector, Chief Executive Officer
SOPHSOPHiA GENETICS SA
Option exercise · 10b5-1 plan
M—
31.9K sh
Jun 26, 2026Jun 29, 2026
traded Jun 26, 2026
+3dSEC Form 4

Evidence

3
LR
Lechleider RobertChief Medical Officer
IMNMImmunome Inc.
Option exercise · 10b5-1 plan
M—
55.0K sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

3
LX
Lin XichenCHIEF SCIENTIFIC OFFICER
GPCRStructure Therapeutics Inc.
Option exercise · 10b5-1 plan
M—
23.6K sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

3
LX
Lin XichenCHIEF SCIENTIFIC OFFICER
GPCRStructure Therapeutics Inc.
Derivative conversion · 10b5-1 plan
C—
23.6K sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

3
LX
Lin XichenCHIEF SCIENTIFIC OFFICER
GPCRStructure Therapeutics Inc.
Option exercise · 10b5-1 plan
M$8,036
23.6K sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

2
AN
Abrahamsen Danielle NicoleChief Accounting Officer
CVLTCOMMVAULT SYSTEMS INC
Grant or award
A—
244 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

1
RN
Rosenberg NickExecutive Vice President
MCBMetropolitan Bank Holding Corp.
Open-market sale · 10b5-1 plan
SELL$9,005
90 sh
Jun 29, 2026Jun 29, 2026
traded Jun 29, 2026
+0dSEC Form 4

Evidence

1
RN
Rosenberg NickExecutive Vice President
MCBMetropolitan Bank Holding Corp.
Open-market sale · 10b5-1 plan
SELL$26K
263 sh
Jun 26, 2026Jun 29, 2026
traded Jun 26, 2026
+3dSEC Form 4

Evidence

1
KR
Kumaraswami RaviPres. Worldwide Field Ops.
RSKDRISKIFIED LTD.
Open-market sale · 10b5-1 plan
SELL$500
100 sh
Jun 26, 2026Jun 29, 2026
traded Jun 26, 2026
+3dSEC Form 4

Evidence

0
DA
D'Amico AndrewDirector
VICRVICOR CORP
Option exercise · 10b5-1 plan
M—
200 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

0
CJ
Camblong JurgiDirector, Chief Executive Officer
SOPHSOPHiA GENETICS SA
Option exercise · 10b5-1 plan
M$101K
31.9K sh
Jun 26, 2026Jun 29, 2026
traded Jun 26, 2026
+3dSEC Form 4

Evidence

0
LX
Lin XichenCHIEF SCIENTIFIC OFFICER
GPCRStructure Therapeutics Inc.
Derivative conversion · 10b5-1 plan
C—
7,878 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

0
SF
Schmidt James FDirector, CFO, Treasurer, Secretary
VICRVICOR CORP
Option exercise · 10b5-1 plan
M—
1,000 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

0
DA
D'Amico AndrewDirector
VICRVICOR CORP
Option exercise · 10b5-1 plan
M—
331 sh
Jun 26, 2026Jun 29, 2026
traded Jun 26, 2026
+3dSEC Form 4

Evidence

0
DA
D'Amico AndrewDirector
VICRVICOR CORP
Option exercise · 10b5-1 plan
M$20K
331 sh
Jun 26, 2026Jun 29, 2026
traded Jun 26, 2026
+3dSEC Form 4

Evidence

0
DA
D'Amico AndrewDirector
VICRVICOR CORP
Option exercise · 10b5-1 plan
M$20K
200 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

0
SF
Schmidt James FDirector, CFO, Treasurer, Secretary
VICRVICOR CORP
Option exercise · 10b5-1 plan
M$100K
1,000 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

50
CO
Calamos Aksia Hedged Strategies Fund (Offshore), Ltd.10% Owner
NANACalamos Aksia Hedged Strategies Fund
Open-market purchase
BUY$405K
39.0K sh
Apr 27, 2026Jun 26, 2026
traded Apr 27, 2026
+60dSEC Form 4

Evidence

49
SG
Swets Larry G JrDirector
GLNDGreenland Energy Co
Open-market purchase
BUY$30K
25.0K sh
May 12, 2026Jun 26, 2026
traded May 12, 2026
+45dSEC Form 4

Evidence

48
HE
Ho EmilyChief Accounting Officer
SNOWSnowflake Inc.
Open-market sale
SELL$432K
1,860 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

45
EH
Employees' Retirement System of the State of Hawaii10% Owner
NANALafayette Square USA, Inc.
Open-market purchase
BUY$20.00M
1.37M sh
Jun 26, 2026Jun 26, 2026
traded Jun 26, 2026
+0dSEC Form 4

Evidence

42
SS
Stout Jay SChief Technology Officer
IMVTImmunovant, Inc.
Open-market sale
SELL$1.27M
33.3K sh
Jun 26, 2026Jun 26, 2026
traded Jun 26, 2026
+0dSEC Form 4

Evidence

42
GM
Gloria MelanieChief Operating Officer
IMVTImmunovant, Inc.
Open-market sale
SELL$563K
14.7K sh
Jun 26, 2026Jun 26, 2026
traded Jun 26, 2026
+0dSEC Form 4

Evidence

42
VC
Van Tuyl ChristopherChief Legal Officer
IMVTImmunovant, Inc.
Open-market sale
SELL$572K
15.0K sh
Jun 26, 2026Jun 26, 2026
traded Jun 26, 2026
+0dSEC Form 4

Evidence

39
ML
McCurry Jennifer LynnChief Accounting Officer
LZBLA-Z-BOY INC
Open-market sale
SELL$153K
3,715 sh
Jun 25, 2026Jun 26, 2026
traded Jun 25, 2026
+1dSEC Form 4

Evidence

38
GT
Girao TiagoChief Financial Officer
IMVTImmunovant, Inc.
Open-market sale
SELL$385K
10.0K sh
Jun 26, 2026Jun 26, 2026
traded Jun 26, 2026
+0dSEC Form 4

Evidence

36
MA
Marchington AndrewChief Financial Officer
GRUSFGrown Rogue International Inc.
Open-market sale
SELL$602
1,400 sh
Apr 22, 2026Jun 26, 2026
traded Apr 22, 2026
+65dSEC Form 4

Evidence

35
SL
Smolyansky LudmilaMember of 10% owner group
LWAYLifeway Foods, Inc.
Open-market sale
SELL$1.20M
40.0K sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

35
SS
Stout Jay SChief Technology Officer
IMVTImmunovant, Inc.
Open-market sale
SELL$262K
6,723 sh
Jun 26, 2026Jun 26, 2026
traded Jun 26, 2026
+0dSEC Form 4

Evidence

35
GM
Gloria MelanieChief Operating Officer
IMVTImmunovant, Inc.
Open-market sale
SELL$116K
2,966 sh
Jun 26, 2026Jun 26, 2026
traded Jun 26, 2026
+0dSEC Form 4

Evidence

35
SE
Smolyansky Edward10% Owner
LWAYLifeway Foods, Inc.
Open-market sale
SELL$1.09M
36.7K sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence